Spi-B and IRF1 activate tumor immunogenicity downstream of the Epstein-Barr virus protein LMP1
{{output}}
Low immunogenicity hinders antitumor immunity and causes resistance to immunotherapies in solid tumors. We previously reported that enforced expression of latent membrane protein 1 (LMP1), encoded by the Epstein-Barr virus, enhances the immunogenicity of B cel... ...